lifestyle.streetregister.com

Author: Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates

New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile

October 28, 2025
Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis

October 28, 2025
TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn’s disease at two years

October 28, 2025
Published in The Lancet: Nipocalimab significantly decreased Sjögren’s disease (SjD) activity and severity through substantial reduction in Sjögren’s-related autoantibodies

October 28, 2025
Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis

October 27, 2025
TACO BELL CHAMPIONS THE TEAM MEMBERS POWERING ITS FUTURE

October 24, 2025
Reynolds® Unwraps a Twist on Thanksgiving with Viral Dubai Chocolate-Inspired Turkey Recipe

October 22, 2025
Brand USA Launches “America the Beautiful” Global Tourism Campaign at Travel Week U.K. & Europe 2025 to Bolster International Tourism’s Impact on U.S. Economy

October 21, 2025